LeMaitre Vascular (LMAT) Competitors

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Does the media refer more to STVN or LMAT?

In the previous week, LeMaitre Vascular had 4 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for LeMaitre Vascular and 4 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.36 beat LeMaitre Vascular's score of 0.63 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger valuation & earnings, STVN or LMAT?

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.19B	6.68	€127.45M	€0.54	48.79
LeMaitre Vascular	$219.86M	9.24	$44.04M	$2.06	43.57

Which has more volatility and risk, STVN or LMAT?

Stevanato Group has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.

Is STVN or LMAT more profitable?

LeMaitre Vascular has a net margin of 20.08% compared to Stevanato Group's net margin of 11.73%. LeMaitre Vascular's return on equity of 13.67% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.73%	10.34%	6.21%
LeMaitre Vascular	20.08%	13.67%	9.14%

Do analysts rate STVN or LMAT?

LeMaitre Vascular has a consensus target price of $97.60, indicating a potential upside of 8.75%. Given LeMaitre Vascular's higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Do institutionals and insiders hold more shares of STVN or LMAT?

84.6% of LeMaitre Vascular shares are owned by institutional investors. 9.5% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

LeMaitre Vascular beats Stevanato Group on 10 of the 16 factors compared between the two stocks.